Rolapitant Hydrochloride

CAS 552292-08-7 1 current recordSmall Molecule

Who holds supplier records for Rolapitant Hydrochloride? 1 organisation holds a current record for Rolapitant Hydrochloride: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Rolapitant Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/rolapitant-hydrochloride

Reading the evidence

  • One current record

    One organisation holds a current DMF or CEP. A record shows a regulatory filing, not current commercial availability or a qualified source for your product.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (1)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Rolapitant Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Rolapitant Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Rolapitant Hydrochloride is a selective neurokinin-1 (NK1) receptor antagonist used as an antiemetic to prevent chemotherapy-induced nausea and vomiting. It functions by blocking the action of neurokinin, a chemical in the brain involved in triggering nausea and vomiting.

Chemical identity

IUPAC name
(5S,8S)-8-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-8-phenyl-1,9-diazaspiro[4.5]decan-2-one;hydrate;hydrochloride
Canonical SMILES
C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC[C@]2(CC[C@]3(CCC(=O)N3)CN2)C4=CC=CC=C4.O.Cl
InChIKey
GZQWMYVDLCUBQX-WVZIYJGPSA-N
Synonyms
Varubi API, rolapitant hcl h20, rolapitant hydrochloride monohydrate, sch-619734, sch619734, varubi

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Substance P/Neurokinin-1 Receptor Antagonist
Mechanism of action
Breast Cancer Resistance Protein Inhibitors; Cytochrome P450 2D6 Inhibitors; Neurokinin 1 Antagonists; P-Glycoprotein Inhibitors

Therapeutic areas

OncologyGastroenterologySupportive Care

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Rolapitant Hydrochloride?

1 organisation holds an active US FDA Type II Drug Master File or a CEP for Rolapitant Hydrochloride: MSN Laboratories Private Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Rolapitant Hydrochloride Drug Master Files are active?

MSN Laboratories Private Limited (DMF 34716). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Rolapitant Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Rolapitant Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.